Liraglutide is approved in Europe for patients with T2DM and mild or moderate kidney damage, but is currently not recommended or should be used with caution in patients with severe renal impairment (130)
Pathogenesis of Diabetes [6,7]
False hope
These preservatives have their own shelf life
Novo Nordisks Peter Johannsen, MD, highlighted the biological signals observed and acknowledged the clinical limitations: subgroup analyses did not reveal meaningful benefit, and any potential responder group would be very small
Contact your healthcare provider if muscle cramps are severe, frequent (daily or multiple times daily), or accompanied by muscle weakness, persistent pain, visible swelling, or dark-colored urine